The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

Classifying and Predicting Response in NETs

Pamela L. Kunz, MD
Published Online: 11:32 PM, Thu January 15, 2015

Pamela L. Kunz, MD, assistant professor, Division of Oncology, Stanford University School of Medicine, discusses classifying neuroendocrine tumors (NETs) and the potential to predict response.

<<< Back to the Gastrointestinal Cancers Symposium conference page

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.